Combination Immunotherapy Targeting Melanoma
NCT06739226
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Melanoma
Interventions
BIOLOGICAL:
Antigen-specific CAR T, CTL and DCvac to treat melanoma.
Sponsor
Shenzhen Geno-Immune Medical Institute